The global market for Gastrointestinal Drugs was valued at US$ 44860 million in the year 2024 and is projected to reach a revised size of US$ 61180 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Gastrointestinal Drugs Market

Gastrointestinal (GI) disorder is a functional disorder or disease which occurs when the main abnormality is the way the body works. In the doctor’s office, no structural or biochemical cause is seen. Gastrointestinal problems occur when nerves or muscles in any portion of the digestive tract do not function in a coordinated fashion, or when the sensitivity of the nerves of the intestines or the way in which the brain controls some of these functions is impaired. In this report, we study the drugs for gastrointestinal.

The key players of Gastrointestinal Drugs include Takeda, AstraZeneca and Bayer, etc. The top three players hold a share over 9%. Asia-Pacific is the largest market, has a share about 25%. In terms of product type, Prescription is the largest segment, occupied for a share of about 64%, and in terms of application, Inflammatory Bowel Disease has a share about 44 percent.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Drugs.

The Gastrointestinal Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastrointestinal Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastrointestinal Drugs Market Report

Report Metric	Details
Report Name	Gastrointestinal Drugs Market
Accounted market size in year	US$ 44860 million
Forecasted market size in 2031	US$ 61180 million
CAGR	4.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Prescription OTC
Segment by Application	Inflammatory Bowel Disease IBS Disease Peptic Ulcer GERD Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda, AstraZeneca, Bayer, Pfizer, Sun Pharma, Teva, Zeria, Perrigo, Eisai Co., Abbvie, Jiangzhong, AOSAIKANG Pharma, Luoxin Pharma, LIVZON, Eastchina Pharma, Bausch Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastrointestinal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Gastrointestinal Drugs Market growing?

Ans: The Gastrointestinal Drugs Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Gastrointestinal Drugs Market size in 2031?

Ans: The Gastrointestinal Drugs Market size in 2031 will be US$ 61180 million.

What is the market share of major companies in Gastrointestinal Drugs Market?

Ans: The top three players hold a share over 9%.

What is the Gastrointestinal Drugs Market share by region?

Ans: Asia-Pacific is the largest market, has a share about 25%.

What is the Gastrointestinal Drugs Market share by type?

Ans: In terms of product type, Prescription is the largest segment, occupied for a share of about 64%, and in terms of application, Inflammatory Bowel Disease has a share about 44 percent.

Who are the main players in the Gastrointestinal Drugs Market report?

Ans: The main players in the Gastrointestinal Drugs Market are Takeda, AstraZeneca, Bayer, Pfizer, Sun Pharma, Teva, Zeria, Perrigo, Eisai Co., Abbvie, Jiangzhong, AOSAIKANG Pharma, Luoxin Pharma, LIVZON, Eastchina Pharma, Bausch Health

What are the Application segmentation covered in the Gastrointestinal Drugs Market report?

Ans: The Applications covered in the Gastrointestinal Drugs Market report are Inflammatory Bowel Disease, IBS Disease, Peptic Ulcer, GERD, Other

What are the Type segmentation covered in the Gastrointestinal Drugs Market report?

Ans: The Types covered in the Gastrointestinal Drugs Market report are Prescription, OTC

1 Gastrointestinal Drugs Market Overview

1.1 Product Definition

1.2 Gastrointestinal Drugs by Type

1.2.1 Global Gastrointestinal Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Prescription

1.2.3 OTC

1.3 Gastrointestinal Drugs by Application

1.3.1 Global Gastrointestinal Drugs Market Value by Application (2024 VS 2031)

1.3.2 Inflammatory Bowel Disease

1.3.3 IBS Disease

1.3.4 Peptic Ulcer

1.3.5 GERD

1.3.6 Other

1.4 Global Gastrointestinal Drugs Market Size Estimates and Forecasts

1.4.1 Global Gastrointestinal Drugs Revenue 2020-2031

1.4.2 Global Gastrointestinal Drugs Sales 2020-2031

1.4.3 Global Gastrointestinal Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Gastrointestinal Drugs Market Competition by Manufacturers

2.1 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Gastrointestinal Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Gastrointestinal Drugs, Product Type & Application

2.7 Global Key Manufacturers of Gastrointestinal Drugs, Date of Enter into This Industry

2.8 Global Gastrointestinal Drugs Market Competitive Situation and Trends

2.8.1 Global Gastrointestinal Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Gastrointestinal Drugs Players Market Share by Revenue

2.8.3 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Gastrointestinal Drugs Market Scenario by Region

3.1 Global Gastrointestinal Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Gastrointestinal Drugs Sales by Region: 2020-2031

3.2.1 Global Gastrointestinal Drugs Sales by Region: 2020-2025

3.2.2 Global Gastrointestinal Drugs Sales by Region: 2026-2031

3.3 Global Gastrointestinal Drugs Revenue by Region: 2020-2031

3.3.1 Global Gastrointestinal Drugs Revenue by Region: 2020-2025

3.3.2 Global Gastrointestinal Drugs Revenue by Region: 2026-2031

3.4 North America Gastrointestinal Drugs Market Facts & Figures by Country

3.4.1 North America Gastrointestinal Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Gastrointestinal Drugs Sales by Country (2020-2031)

3.4.3 North America Gastrointestinal Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Gastrointestinal Drugs Market Facts & Figures by Country

3.5.1 Europe Gastrointestinal Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Gastrointestinal Drugs Sales by Country (2020-2031)

3.5.3 Europe Gastrointestinal Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Gastrointestinal Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Gastrointestinal Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Gastrointestinal Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Gastrointestinal Drugs Market Facts & Figures by Country

3.7.1 Latin America Gastrointestinal Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Gastrointestinal Drugs Sales by Country (2020-2031)

3.7.3 Latin America Gastrointestinal Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Gastrointestinal Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Gastrointestinal Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Gastrointestinal Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Gastrointestinal Drugs Sales by Type (2020-2031)

4.1.1 Global Gastrointestinal Drugs Sales by Type (2020-2025)

4.1.2 Global Gastrointestinal Drugs Sales by Type (2026-2031)

4.1.3 Global Gastrointestinal Drugs Sales Market Share by Type (2020-2031)

4.2 Global Gastrointestinal Drugs Revenue by Type (2020-2031)

4.2.1 Global Gastrointestinal Drugs Revenue by Type (2020-2025)

4.2.2 Global Gastrointestinal Drugs Revenue by Type (2026-2031)

4.2.3 Global Gastrointestinal Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Gastrointestinal Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Gastrointestinal Drugs Sales by Application (2020-2031)

5.1.1 Global Gastrointestinal Drugs Sales by Application (2020-2025)

5.1.2 Global Gastrointestinal Drugs Sales by Application (2026-2031)

5.1.3 Global Gastrointestinal Drugs Sales Market Share by Application (2020-2031)

5.2 Global Gastrointestinal Drugs Revenue by Application (2020-2031)

5.2.1 Global Gastrointestinal Drugs Revenue by Application (2020-2025)

5.2.2 Global Gastrointestinal Drugs Revenue by Application (2026-2031)

5.2.3 Global Gastrointestinal Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Gastrointestinal Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Takeda

6.1.1 Takeda Company Information

6.1.2 Takeda Description and Business Overview

6.1.3 Takeda Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Takeda Gastrointestinal Drugs Product Portfolio

6.1.5 Takeda Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Company Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 AstraZeneca Gastrointestinal Drugs Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Bayer

6.3.1 Bayer Company Information

6.3.2 Bayer Description and Business Overview

6.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bayer Gastrointestinal Drugs Product Portfolio

6.3.5 Bayer Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer Gastrointestinal Drugs Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Sun Pharma

6.5.1 Sun Pharma Company Information

6.5.2 Sun Pharma Description and Business Overview

6.5.3 Sun Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Sun Pharma Gastrointestinal Drugs Product Portfolio

6.5.5 Sun Pharma Recent Developments/Updates

6.6 Teva

6.6.1 Teva Company Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Teva Gastrointestinal Drugs Product Portfolio

6.6.5 Teva Recent Developments/Updates

6.7 Zeria

6.7.1 Zeria Company Information

6.7.2 Zeria Description and Business Overview

6.7.3 Zeria Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Zeria Gastrointestinal Drugs Product Portfolio

6.7.5 Zeria Recent Developments/Updates

6.8 Perrigo

6.8.1 Perrigo Company Information

6.8.2 Perrigo Description and Business Overview

6.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Perrigo Gastrointestinal Drugs Product Portfolio

6.8.5 Perrigo Recent Developments/Updates

6.9 Eisai Co.

6.9.1 Eisai Co. Company Information

6.9.2 Eisai Co. Description and Business Overview

6.9.3 Eisai Co. Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Eisai Co. Gastrointestinal Drugs Product Portfolio

6.9.5 Eisai Co. Recent Developments/Updates

6.10 Abbvie

6.10.1 Abbvie Company Information

6.10.2 Abbvie Description and Business Overview

6.10.3 Abbvie Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Abbvie Gastrointestinal Drugs Product Portfolio

6.10.5 Abbvie Recent Developments/Updates

6.11 Jiangzhong

6.11.1 Jiangzhong Company Information

6.11.2 Jiangzhong Description and Business Overview

6.11.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Jiangzhong Gastrointestinal Drugs Product Portfolio

6.11.5 Jiangzhong Recent Developments/Updates

6.12 AOSAIKANG Pharma

6.12.1 AOSAIKANG Pharma Company Information

6.12.2 AOSAIKANG Pharma Description and Business Overview

6.12.3 AOSAIKANG Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 AOSAIKANG Pharma Gastrointestinal Drugs Product Portfolio

6.12.5 AOSAIKANG Pharma Recent Developments/Updates

6.13 Luoxin Pharma

6.13.1 Luoxin Pharma Company Information

6.13.2 Luoxin Pharma Description and Business Overview

6.13.3 Luoxin Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Luoxin Pharma Gastrointestinal Drugs Product Portfolio

6.13.5 Luoxin Pharma Recent Developments/Updates

6.14 LIVZON

6.14.1 LIVZON Company Information

6.14.2 LIVZON Description and Business Overview

6.14.3 LIVZON Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 LIVZON Gastrointestinal Drugs Product Portfolio

6.14.5 LIVZON Recent Developments/Updates

6.15 Eastchina Pharma

6.15.1 Eastchina Pharma Company Information

6.15.2 Eastchina Pharma Description and Business Overview

6.15.3 Eastchina Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Eastchina Pharma Gastrointestinal Drugs Product Portfolio

6.15.5 Eastchina Pharma Recent Developments/Updates

6.16 Bausch Health

6.16.1 Bausch Health Company Information

6.16.2 Bausch Health Description and Business Overview

6.16.3 Bausch Health Gastrointestinal Drugs Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Bausch Health Gastrointestinal Drugs Product Portfolio

6.16.5 Bausch Health Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Gastrointestinal Drugs Industry Chain Analysis

7.2 Gastrointestinal Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Gastrointestinal Drugs Production Mode & Process Analysis

7.4 Gastrointestinal Drugs Sales and Marketing

7.4.1 Gastrointestinal Drugs Sales Channels

7.4.2 Gastrointestinal Drugs Distributors

7.5 Gastrointestinal Drugs Customer Analysis

8 Gastrointestinal Drugs Market Dynamics

8.1 Gastrointestinal Drugs Industry Trends

8.2 Gastrointestinal Drugs Market Drivers

8.3 Gastrointestinal Drugs Market Challenges

8.4 Gastrointestinal Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Bayer

Pfizer Inc

TEVA

Perrigo

Jiangzhong

List of Tables

Table 1. Global Gastrointestinal Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Gastrointestinal Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Gastrointestinal Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Gastrointestinal Drugs Sales (M Units) of Key Manufacturers (2020-2025)

Table 5. Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Gastrointestinal Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Gastrointestinal Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Gastrointestinal Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Gastrointestinal Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Gastrointestinal Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Gastrointestinal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Gastrointestinal Drugs Sales by Region (2020-2025) & (M Units)

Table 18. Global Gastrointestinal Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Gastrointestinal Drugs Sales by Region (2026-2031) & (M Units)

Table 20. Global Gastrointestinal Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Gastrointestinal Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Gastrointestinal Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Gastrointestinal Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Gastrointestinal Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Gastrointestinal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Gastrointestinal Drugs Sales by Country (2020-2025) & (M Units)

Table 27. North America Gastrointestinal Drugs Sales by Country (2026-2031) & (M Units)

Table 28. North America Gastrointestinal Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Gastrointestinal Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Gastrointestinal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Gastrointestinal Drugs Sales by Country (2020-2025) & (M Units)

Table 32. Europe Gastrointestinal Drugs Sales by Country (2026-2031) & (M Units)

Table 33. Europe Gastrointestinal Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Gastrointestinal Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Gastrointestinal Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Gastrointestinal Drugs Sales by Region (2020-2025) & (M Units)

Table 37. Asia Pacific Gastrointestinal Drugs Sales by Region (2026-2031) & (M Units)

Table 38. Asia Pacific Gastrointestinal Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Gastrointestinal Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Gastrointestinal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Gastrointestinal Drugs Sales by Country (2020-2025) & (M Units)

Table 42. Latin America Gastrointestinal Drugs Sales by Country (2026-2031) & (M Units)

Table 43. Latin America Gastrointestinal Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Gastrointestinal Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Gastrointestinal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Gastrointestinal Drugs Sales by Country (2020-2025) & (M Units)

Table 47. Middle East and Africa Gastrointestinal Drugs Sales by Country (2026-2031) & (M Units)

Table 48. Middle East and Africa Gastrointestinal Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Gastrointestinal Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Gastrointestinal Drugs Sales (M Units) by Type (2020-2025)

Table 51. Global Gastrointestinal Drugs Sales (M Units) by Type (2026-2031)

Table 52. Global Gastrointestinal Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Gastrointestinal Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Gastrointestinal Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Gastrointestinal Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Gastrointestinal Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Gastrointestinal Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Gastrointestinal Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Gastrointestinal Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Gastrointestinal Drugs Sales (M Units) by Application (2020-2025)

Table 61. Global Gastrointestinal Drugs Sales (M Units) by Application (2026-2031)

Table 62. Global Gastrointestinal Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Gastrointestinal Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Gastrointestinal Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Gastrointestinal Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Gastrointestinal Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Gastrointestinal Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Gastrointestinal Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Gastrointestinal Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Takeda Company Information

Table 71. Takeda Description and Business Overview

Table 72. Takeda Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Takeda Gastrointestinal Drugs Product

Table 74. Takeda Recent Developments/Updates

Table 75. AstraZeneca Company Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. AstraZeneca Gastrointestinal Drugs Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. Bayer Company Information

Table 81. Bayer Description and Business Overview

Table 82. Bayer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Bayer Gastrointestinal Drugs Product

Table 84. Bayer Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer Gastrointestinal Drugs Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Sun Pharma Company Information

Table 91. Sun Pharma Description and Business Overview

Table 92. Sun Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Sun Pharma Gastrointestinal Drugs Product

Table 94. Sun Pharma Recent Developments/Updates

Table 95. Teva Company Information

Table 96. Teva Description and Business Overview

Table 97. Teva Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Teva Gastrointestinal Drugs Product

Table 99. Teva Recent Developments/Updates

Table 100. Zeria Company Information

Table 101. Zeria Description and Business Overview

Table 102. Zeria Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Zeria Gastrointestinal Drugs Product

Table 104. Zeria Recent Developments/Updates

Table 105. Perrigo Company Information

Table 106. Perrigo Description and Business Overview

Table 107. Perrigo Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Perrigo Gastrointestinal Drugs Product

Table 109. Perrigo Recent Developments/Updates

Table 110. Eisai Co. Company Information

Table 111. Eisai Co. Description and Business Overview

Table 112. Eisai Co. Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Eisai Co. Gastrointestinal Drugs Product

Table 114. Eisai Co. Recent Developments/Updates

Table 115. Abbvie Company Information

Table 116. Abbvie Description and Business Overview

Table 117. Abbvie Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Abbvie Gastrointestinal Drugs Product

Table 119. Abbvie Recent Developments/Updates

Table 120. Jiangzhong Company Information

Table 121. Jiangzhong Description and Business Overview

Table 122. Jiangzhong Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Jiangzhong Gastrointestinal Drugs Product

Table 124. Jiangzhong Recent Developments/Updates

Table 125. AOSAIKANG Pharma Company Information

Table 126. AOSAIKANG Pharma Description and Business Overview

Table 127. AOSAIKANG Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. AOSAIKANG Pharma Gastrointestinal Drugs Product

Table 129. AOSAIKANG Pharma Recent Developments/Updates

Table 130. Luoxin Pharma Company Information

Table 131. Luoxin Pharma Description and Business Overview

Table 132. Luoxin Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Luoxin Pharma Gastrointestinal Drugs Product

Table 134. Luoxin Pharma Recent Developments/Updates

Table 135. LIVZON Company Information

Table 136. LIVZON Description and Business Overview

Table 137. LIVZON Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. LIVZON Gastrointestinal Drugs Product

Table 139. LIVZON Recent Developments/Updates

Table 140. Eastchina Pharma Company Information

Table 141. Eastchina Pharma Description and Business Overview

Table 142. Eastchina Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Eastchina Pharma Gastrointestinal Drugs Product

Table 144. Eastchina Pharma Recent Developments/Updates

Table 145. Bausch Health Company Information

Table 146. Bausch Health Description and Business Overview

Table 147. Bausch Health Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Bausch Health Gastrointestinal Drugs Product

Table 149. Bausch Health Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Gastrointestinal Drugs Distributors List

Table 153. Gastrointestinal Drugs Customers List

Table 154. Gastrointestinal Drugs Market Trends

Table 155. Gastrointestinal Drugs Market Drivers

Table 156. Gastrointestinal Drugs Market Challenges

Table 157. Gastrointestinal Drugs Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Gastrointestinal Drugs

Figure 2. Global Gastrointestinal Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gastrointestinal Drugs Market Share by Type: 2024 & 2031

Figure 4. Prescription Product Picture

Figure 5. OTC Product Picture

Figure 6. Global Gastrointestinal Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Gastrointestinal Drugs Market Share by Application: 2024 & 2031

Figure 8. Inflammatory Bowel Disease

Figure 9. IBS Disease

Figure 10. Peptic Ulcer

Figure 11. GERD

Figure 12. Other

Figure 13. Global Gastrointestinal Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Gastrointestinal Drugs Market Size (2020-2031) & (US$ Million)

Figure 15. Global Gastrointestinal Drugs Sales (2020-2031) & (M Units)

Figure 16. Global Gastrointestinal Drugs Average Price (US$/Unit) & (2020-2031)

Figure 17. Gastrointestinal Drugs Report Years Considered

Figure 18. Gastrointestinal Drugs Sales Share by Manufacturers in 2024

Figure 19. Global Gastrointestinal Drugs Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Gastrointestinal Drugs Players: Market Share by Revenue in Gastrointestinal Drugs in 2024

Figure 21. Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Gastrointestinal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Gastrointestinal Drugs Sales Market Share by Country (2020-2031)

Figure 24. North America Gastrointestinal Drugs Revenue Market Share by Country (2020-2031)

Figure 25. United States Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Gastrointestinal Drugs Sales Market Share by Country (2020-2031)

Figure 28. Europe Gastrointestinal Drugs Revenue Market Share by Country (2020-2031)

Figure 29. Germany Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region (2020-2031)

Figure 36. China Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Gastrointestinal Drugs Sales Market Share by Country (2020-2031)

Figure 44. Latin America Gastrointestinal Drugs Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Gastrointestinal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Gastrointestinal Drugs by Type (2020-2031)

Figure 54. Global Revenue Market Share of Gastrointestinal Drugs by Type (2020-2031)

Figure 55. Global Gastrointestinal Drugs Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Gastrointestinal Drugs by Application (2020-2031)

Figure 57. Global Revenue Market Share of Gastrointestinal Drugs by Application (2020-2031)

Figure 58. Global Gastrointestinal Drugs Price (US$/Unit) by Application (2020-2031)

Figure 59. Gastrointestinal Drugs Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions